Ab&B Bio-Tech CO., LTD. JS (HKG:2627)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
49.12
+0.46 (0.95%)
Sep 3, 2025, 4:08 PM HKT

HKG:2627 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Mar '25 Dec '24 Dec '23
259.72259.6152.17
Revenue Growth (YoY)
-397.65%-
Cost of Revenue
107.14108.1672.51
Gross Profit
152.58151.46-20.34
Selling, General & Admin
206.6199.81132.39
Research & Development
208.08204.62280.86
Other Operating Expenses
0.912.97-
Operating Expenses
415.64407.47413.3
Operating Income
-263.06-256.01-433.65
Interest Expense
-19.27-17.71-6.61
Interest & Investment Income
0.320.473.16
Other Non Operating Income (Expenses)
0.2315.3511.04
EBT Excluding Unusual Items
-281.78-257.9-426.05
Gain (Loss) on Sale of Investments
0.140.241.35
Gain (Loss) on Sale of Assets
-1.06-1.06-0.04
Pretax Income
-282.7-258.72-424.74
Net Income
-282.7-258.72-424.74
Net Income to Common
-282.7-258.72-424.74
Shares Outstanding (Basic)
360360360
Shares Outstanding (Diluted)
360360360
EPS (Basic)
-0.79-0.72-1.18
EPS (Diluted)
-0.79-0.72-1.18
Free Cash Flow
-294.2-399.08-571.29
Free Cash Flow Per Share
-0.82-1.11-1.59
Gross Margin
58.75%58.34%-39.00%
Operating Margin
-101.28%-98.61%-831.25%
Profit Margin
-108.85%-99.66%-814.18%
Free Cash Flow Margin
-113.28%-153.72%-1095.09%
EBITDA
-209.93-206.54-394.1
EBITDA Margin
-80.83%-79.56%-
D&A For EBITDA
53.1249.4739.54
EBIT
-263.06-256.01-433.65
EBIT Margin
-101.28%-98.61%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.